Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | HDFC MNC Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | HDFC |
| NAV | ₹40.2296 | ₹14.7710 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 10.9 years | 3.7 years |
| Expense ratio | 1.1% | 1.8% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 68.00 | 20.20 |
Returns
| Tata India Pharma & Healthcare Fund | HDFC MNC Fund | |
|---|---|---|
| 1 month | +9.87% | +7.58% |
| 3 months | +1.12% | −0.75% |
| 6 months | +7.63% | +8.05% |
| YTD | +13.73% | +5.43% |
| 1 year | +11.82% | +6.62% |
| 3 years (CAGR) | +18.74% | +7.87% |
| 5 years (CAGR) | +16.00% | — |
| 10 years (CAGR) | +15.95% | — |
| Since launch | +13.58% | +11.07% |
Risk
| Tata India Pharma & Healthcare Fund | HDFC MNC Fund | |
|---|---|---|
| Volatility | 15.7% | 17.1% |
| Downside volatility | 10.0% | 12.5% |
| Sharpe | 0.78 | 0.08 |
| Sortino | 1.23 | 0.11 |
| Calmar | 1.12 | 0.32 |
| Return / risk | 1.19 | 0.46 |
| Deepest fall | −19.84% | −24.53% |
| Days to recover | 375 | — |
| Below its high | +0.00% | −5.89% |
Against benchmark
| Tata India Pharma & Healthcare Fund | HDFC MNC Fund | |
|---|---|---|
| Alpha | −2.99% | −3.75% |
| Beta | 1.00 | 0.87 |
| R² | 90.2% | 89.3% |
| Up capture | 91.3% | 82.1% |
| Down capture | 102.0% | 95.1% |
| Tracking error | 4.9% | 6.1% |
| Information ratio | −0.62 | −0.76 |
| Treynor | 0.11 | 0.01 |
Consistency
| Tata India Pharma & Healthcare Fund | HDFC MNC Fund | |
|---|---|---|
| Best 1-year | +76.35% | +36.06% |
| Middle 1-year | +8.85% | +3.96% |
| Worst 1-year | −17.32% | −11.20% |
| 1-year periods with a loss | 29.0% | 33.8% |
| Middle 3-year | +21.13% | +8.05% |
| Positive months | 63.9% | 63.9% |
| Best day | +3.34% | +3.18% |
| Worst day | −3.09% | −3.84% |
| Worst 5% day | −1.35% | −1.50% |
| Positive days | 55.4% | 54.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | HDFC MNC Fund | |
|---|---|---|
| 5-year XIRR | +18.07% | — |
| 5-year value | ₹9,50,065 | — |
| 3-year XIRR | +13.31% | +5.49% |
| 1-year XIRR | +18.41% | +10.78% |
Holdings overlap i
Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
- Tata India Pharma & Healthcare Fund: no monthly portfolio filing from Tata is loaded yet, so it is left out here.
- HDFC MNC Fund: no monthly portfolio filing from HDFC is loaded yet, so it is left out here.